Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 12 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-10 Jenkins John Kenneth Director Sale 10b5-1 −4,800 $7.91 $38K 3,833
2026-05-19 Jenkins John Kenneth Director Grant or award +3,800 8,633
2026-05-19 Jenkins John Kenneth Director Grant or award · Stock options (right to buy) +12,300 12,300
2025-05-30 Jenkins John Kenneth Director Sale 10b5-1 −2,783 $7.35 $20K 33
2025-05-30 Jenkins John Kenneth Director Grant or award 10b5-1 +4,800 4,833
2025-05-30 Jenkins John Kenneth Director Grant or award · Stock options (right to buy) 10b5-1 +16,000 16,000
2024-05-30 Jenkins John Kenneth Director Grant or award +2,783 2,816
2024-05-16 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +2,783 2,783
2023-05-18 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +5,300 5,300
2022-05-18 Jenkins John Kenneth Director Grant or award · Stock Option(right to buy) +79,600 79,600
2021-06-17 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +58,200 58,200
2021-06-17 Jenkins John Kenneth Director Grant or award · Stock Option (right to buy) +58,200 58,200
2020-05-20 Jenkins John Kenneth Director Grant or award · Stock Option(right to buy) +40,500 40,500
2019-05-22 Jenkins John Kenneth Director Grant or award · Stock Option(right to buy) +33,300 33,300
2019-03-15 Jenkins John Kenneth Director Purchase +1,000 $6.98 $7K 1,000
2018-06-05 Jenkins John Kenneth Director Grant or award · Stock Option(right to buy) +68,000 68,000

Page 1 of 1 · 16 trades